{"id":837341,"date":"2025-04-15T08:11:29","date_gmt":"2025-04-15T12:11:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/"},"modified":"2025-04-15T08:11:29","modified_gmt":"2025-04-15T12:11:29","slug":"evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/","title":{"rendered":"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels"},"content":{"rendered":"

<\/p>\n

Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122<\/sup> Injectable Hyaluronic Acid Gels<\/b><\/p>\n

NEWPORT BEACH, Calif.–(BUSINESS WIRE<\/a>)–Evolus, Inc.<\/a> (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the launch of its bold new campaign, \u201cDrop the F Word,\u201d ahead of the upcoming commercial launch of Evolysse\u2122<\/sup>. Designed to challenge outdated perceptions and language in the aesthetics industry, the campaign introduces Evolysse\u2122<\/sup>, a collection of injectable hyaluronic acid (HA) gels specifically designed to deliver long-lasting, natural-looking results for the treatment of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds.\n<\/p>\n

\nThe \u201cDrop the F Word\u201d campaign aims to reenergize the injectable HA category and address growing filler fatigue. Increasingly, consumers associate the term \u201cfiller\u201d with unnatural results and an overfilled look, perceptions that no longer reflect the advancement of today\u2019s products or consumer desires. In response, Evolus conducted in-depth research with customers and consumers to better understand these shifting attitudes. The insights were clear, \u201cfiller\u201d is an outdated term and no longer serves the category. As a result, Evolus tested new ways to reframe the category and is introducing Evolysse\u2122<\/sup> as a collection of injectable hyaluronic acid gels, removing \u201cfiller,\u201d the \u201cF word,\u201d from its vernacular. This approach better reflects the innovation behind the collection and the results consumers expect today.\n<\/p>\n

\n\u201cAs aesthetic treatments evolve, the conversation around them must evolve too,\u201d said David Moatazedi, President and Chief Executive Officer of Evolus. \u201cWith the ‘Drop the F Word’ campaign, we\u2019re pushing the industry forward, replacing the outdated term ‘filler’ with a more modern, meaningful conversation centered around personalization, education, and natural-looking results. Evolysse\u2122<\/sup> isn\u2019t just another filler, it\u2019s the future of performance beauty.\u201d\n<\/p>\n

\nWith the first breakthrough in HA technology in over a decade, Evolysse\u2122<\/sup> marks a new chapter in aesthetic injectables, moving beyond the traditional concept of \u201cfillers\u201d and toward a new standard of personalized, natural-looking outcomes. Evolysse\u2122<\/sup> is manufactured utilizing Cold-X\u2122<\/sup> technology, an innovative manufacturing process designed to better preserve the natural structure of the HA molecule. The result is a collection of injectable HA gels that deliver natural-looking outcomes and align with the evolving expectations of today\u2019s aesthetic consumers.\n<\/p>\n

\nThrough this initiative, Evolus is inviting patients, practitioners, and the broader beauty industry to rethink how aesthetic treatments are discussed, embraced, and delivered. The campaign also underscores the company\u2019s broader mission and modern approach to elevate the aesthetics experience, prioritizing confidence and informed decision-making across all stakeholders.\n<\/p>\n

\nWith Evolysse\u2122<\/sup>, Evolus is not only launching an innovative injectable HA collection but also leading a cultural shift in how beauty treatments are perceived. This campaign and product launch together represent a commitment to advancing performance beauty that reflects the expectations of today\u2019s beauty consumer.\n<\/p>\n

About Evolus, Inc.<\/b><\/p>\n

\nEvolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau\u00ae<\/sup> (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse\u2122<\/sup>, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com<\/a>, and follow us on LinkedIn<\/a>, X<\/a>, Instagram<\/a> or Facebook<\/a>.\n<\/p>\n

\nJeuveau\u00ae<\/sup> and Nuceiva\u00ae<\/sup>, are registered trademarks and Evolysse\u2122<\/sup> is a trademark of Evolus, Inc.
\n
Cold-X\u2122 is a trademark of Symatese Group S.A.S.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250415249207\/en\/<\/a><\/span><\/p>\n

Evolus Contacts:
\n<\/b>
Investors:
\n<\/span>
Nareg Sagherian
\n
Vice President, Head of Global Investor Relations and Corporate Communications
\n
Tel: 248-202-9267
\n
Email: ir@evolus.com
\n<\/a><\/p>\n

Media<\/span>:
\n
Email: media@evolus.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Luxury Marketing Communications Biotechnology Fashion Health Cosmetics Pharmaceutical Retail<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the launch of its bold new campaign, \u201cDrop the F Word,\u201d ahead of the upcoming commercial launch of Evolysse\u2122. Designed to challenge outdated perceptions and language in the aesthetics industry, the campaign introduces Evolysse\u2122, a collection of injectable hyaluronic acid (HA) gels specifically designed to deliver long-lasting, natural-looking results for the treatment of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds. The \u201cDrop the F Word\u201d campaign aims to reenergize the injectable HA category and address … <\/p>\n

Continue reading “Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-837341","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEvolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the launch of its bold new campaign, \u201cDrop the F Word,\u201d ahead of the upcoming commercial launch of Evolysse\u2122. Designed to challenge outdated perceptions and language in the aesthetics industry, the campaign introduces Evolysse\u2122, a collection of injectable hyaluronic acid (HA) gels specifically designed to deliver long-lasting, natural-looking results for the treatment of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds. The \u201cDrop the F Word\u201d campaign aims to reenergize the injectable HA category and address … Continue reading "Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T12:11:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415249207r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels\",\"datePublished\":\"2025-04-15T12:11:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/\"},\"wordCount\":657,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415249207r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/\",\"name\":\"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415249207r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-04-15T12:11:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415249207r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250415249207r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/","og_locale":"en_US","og_type":"article","og_title":"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels - Market Newsdesk","og_description":"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the launch of its bold new campaign, \u201cDrop the F Word,\u201d ahead of the upcoming commercial launch of Evolysse\u2122. Designed to challenge outdated perceptions and language in the aesthetics industry, the campaign introduces Evolysse\u2122, a collection of injectable hyaluronic acid (HA) gels specifically designed to deliver long-lasting, natural-looking results for the treatment of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds. The \u201cDrop the F Word\u201d campaign aims to reenergize the injectable HA category and address … Continue reading \"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-15T12:11:29+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415249207r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels","datePublished":"2025-04-15T12:11:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/"},"wordCount":657,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415249207r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/","name":"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415249207r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-04-15T12:11:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415249207r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250415249207r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evolus-launches-drop-the-f-word-campaign-in-advance-of-the-commercial-launch-of-evolysse-injectable-hyaluronic-acid-gels\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evolus Launches \u201cDrop the F Word\u201d Campaign in Advance of the Commercial Launch of Evolysse\u2122 Injectable Hyaluronic Acid Gels"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=837341"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837341\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=837341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=837341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=837341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}